Skip to main content
. 2023 Jul 25;15:11. doi: 10.1186/s41479-023-00113-9

Table 2.

Clinical management and outcome of children with respiratory symptoms not admitted to hospital, before and after the intervention

Management and outcome Before After p-value
Hospital admission 102 (7.9) 14 (8.4) 0.76
Discharged home N = 1188 N = 152
Phone call contact
 Day 4 901 (75.8) 150 (98.7)  < 0.001
 Day 8 788 (66.3) 149 (98.0)  < 0.001
Antibiotic treatment 556 (46.8) 54 (35.5) 0.009
 Amoxicillin 74 (13.3) 4 (7.4) 0.29
 Amoxicillin/clavulanate 247 (44.4) 25 (46.3) 0.89
 Cefuroxime 92 (16.5) 15 (27.7) 0.06
 Macrolide 110 (19.8) 9 (16.7) 0.72
 Amoxicillin + macrolide 1 (0.2) 0 -
 Amoxicillin/clavulanate + macrolide 25 (4.6) 0 -
 Cefuroxime + macrolide 6 (1.0) 0 -
 Clindamycin 1 (0.2) 0 -
 Cephalexin 0 1 (1.9) -
Antibiotic treatment by age group
 12–23 months 322 (57.9) 29 (53.6) 0.57
 24–59 months 234 (42.1) 25 (46.4)
Representation within 1 week N = 141 (11.9) N = 10 (6.6) 0.10
Reason revisit
 Prolonged cough 42 (29.8) 0 -
 High fevera 33 (23.4) 7 (70.0) 0.004
 Cough and fever 14 (9.9) 1 (10.0) -
 Breathlessness 4 (2.9) 1 (10.0) -
 Prolonged runny nose 2 (1.3) 0 -
 Routine follow up by physician 19 (13.5) 1 (10.0) -
 Other 27 (19.2) 0 -
Diagnosis at representation
 Pneumonia 45 (31.9) 1 (10.0)
 Asthma 7 (5.0) 2 (20.0) -
 Bronchiolitis 6 (4.3) 0 -
 Bronchitis 8 (5.7) 0 -
 URTI 58 (41.1) 2 (20.0) -
 Others (viral infections) 17 (12.0) 5 (50.0) -
Antibiotic treatment at representation 70 (49.6) 2 (20.0)
 Macrolide 8 (11.4) 1 (50) -
 Cefuroxime 13 (18.6) 1 (50) -
 Amoxicillin 1 (1.4) 0 -
 Amoxicillin/clavulanate 38 (5.3) 0 -
 Amoxicillin/clavulanate + macrolide 6 (8.6) 0 -
 Cefuroxime + macrolide 4 (5.7) 0 -
Hospital admission at representation N = 25 (17.7) N = 3 (30.0) 0.40
 Admitted to DHWC 18 (72.0) 2 (66.7) 1.00
 Admitted to another hospital 7 (28.0) 1 (33.3) -

URTI upper respiratory tract infection, DHWC the Da Nang Hospital for Women and Children

asubjective fever as reported by the parent